Results 121 to 130 of about 22,786 (211)

Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide. [PDF]

Diabetol Int
Takebayashi K, Iemura Y, Yamauchi M, Hara K, Tsuchiya T, Machida S, Hashimoto K.   +6 more
europepmc   +1 more source

DRD2 activation inhibits choroidal neovascularization in patients with Parkinson’s disease and age-related macular degeneration

The Journal of Clinical Investigation
Neovascular age-related macular degeneration (nAMD) remains a major cause of visual impairment and puts considerable burden on patients and health care systems.
Thibaud Mathis, Florian Baudin, Anne-Sophie Mariet, Sébastien Augustin, Marion Bricout, Lauriane Przegralek, Christophe Roubeix, Éric Benzenine, Guillaume Blot, Caroline Nous, Laurent Kodjikian, Martine Mauget-Faÿsse, José-Alain Sahel, Robin Plevin, Christina Zeitz, Cécile Delarasse, Xavier Guillonneau, Catherine Creuzot-Garcher, Catherine Quantin, Stéphane Hunot, Florian Sennlaub   +20 more
doaj   +1 more source

Associations of <i>TNFRSF10A</i> with Central Serous Chorioretinopathy, Polypoidal Choroidal Vasculopathy, and Age-Related Macular Degeneration. [PDF]

Ophthalmol Sci
Chen ZJ, Yu J, Ng DSC, Ho M, Zhu X, Brelen ME, Young AL, Yam JC, Tham CC, Pang CP, Chen LJ.   +10 more
europepmc   +1 more source

Scalable Molecular Dynamics with NAMD [PDF]

, 2016
openaire   +1 more source

Expression of aqueous cytokines and their correlation with retinal morphological biomarkers in nAMD patients. [PDF]

PLoS One
Zeng J, Shang W, Ren P, Ke X, Zhao Y, Liu G, Liu J, Lu F, Jiang X.   +8 more
europepmc   +1 more source

Real-World Outcomes of Switching to Faricimab in Treatment-Experienced and Resistant Neovascular Age-Related Macular Degeneration: A Single-Centre Retrospective Study. [PDF]

Clin Ophthalmol
Stewart C, Bhangu JS, Swarnkar PK, Rifat M, Khalid S, Al-Janabi A, Awad MH, Williams GS.   +7 more
europepmc   +1 more source

SRF and SHRM in nAMD: Retrospective Analysis of Visual Prognosis. [PDF]

Clin Ophthalmol
Wu W, Guo H, Wang L, Yang M.
europepmc   +1 more source

Multidimensional evaluation of the potential impact of faricimab availability on healthcare system accessibility for retinal disease treatment in Poland. [PDF]

BMC Health Serv Res
Seweryn M, Kopel J, Augustynska J, Mikołajewicz A, Toro MD, Rejdak R.   +5 more
europepmc   +1 more source

Short term real-world effectiveness of faricimab in neovascular age-related macular degeneration patients in the Republic of Korea. [PDF]

Sci Rep
Chung DH, Jee D, Roh YJ, Ra H, Lee MY, Won JY, Shin JA, Jung SH, Park YH.   +8 more
europepmc   +1 more source

Clinical Outcomes of High-Dose Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Bousamri A, Al-Shehri M, Mestarihi M, Almutairi TB, Alaredhi M, Mahanna B, Alharbi F.   +6 more
europepmc   +1 more source